COMMUNIQUÉS West-GlobeNewswire

Valneva SE - Declaration of voting rights - December 2025
08/01/2026
VALNEVA Declaration of shares and voting rights December 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot Saint Joseph [...]
Déclaration d'actions et de droits de vote de la société Valneva SE - décembre 2025
08/01/2026
VALNEVA Déclaration d’actions et de droits de vote 31 décembre 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : [...]
MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease
08/01/2026
Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation Award Expands iNKT platform into transplantation with an off-the-shelf, HLA-independent, lymphodepletion-free [...]
Easy Environmental Solutions Enters 2026 With Accelerated Global Momentum and a Clear Path to Scale
08/01/2026
Company surpasses 2025 international development targets and advances toward multi-continent deployment of disruptive integrated soil and water technologies MANKATO, Minn., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Easy [...]
Vystar Corp. Submits Binding Letter of Intent to Acquire Stake in GoPaid.com LLC and Form Strategic Partnership with Capital R3alm to Launch R3alm Oracle and R3alm Collectibles
08/01/2026
Worcester, Massachusetts, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCQB: VYST ), a diversified innovation company with operations spanning eco-friendly products and collectibles monetization, today [...]
ALK to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco
08/01/2026
ALK ( ALKB:DC / OMX: ALK B ) today announced that the company’s president & CEO, Peter Halling, is scheduled to give a company presentation at the 44 th Annual J.P. Morgan Healthcare Conference in San Francisco on [...]
ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
08/01/2026
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat [...]
LucyRx Appoints Christin Bassett as Chief Legal Officer
08/01/2026
Bassett brings deep PBM regulatory and compliance expertise to support rapid growth BETHESDA, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- LucyRx, an independent pharmacy benefit manager (PBM) known for simplifying access to [...]
Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T
08/01/2026
1H 2026 Catalyst Stack Anticipated to Validate Scalable, Off-the-Shelf CAR T in Oncology and Autoimmune Disease Interim Futility Analysis of MRD Clearance from the Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene [...]
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates
08/01/2026
Received $35.8 million in gross proceeds from Series B warrant exercises, including full exercise by Coastlands Capital, Frazier Life Sciences and Gilead Sciences, Inc., and extended anticipated cash runway into second [...]
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook
08/01/2026
Company achieved significant commercial progress in 2025, generating approximately $378 million in product revenue 1 IBSRELA achieved $274 million in revenue in 2025, representing 73% growth vs. 2024 1 IBSRELA expected [...]
ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004
08/01/2026
- First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s choice of chemotherapy in HER2-positive metastatic breast cancer; interim analysis anticipated [...]
RenovoRx To Announce Promising New Clinical Data Using its TAMP™ Therapy Platform in an Abstract to be Presented at ASCO GI 2026
08/01/2026
New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx’s TAMP Therapy Platform as a Targeted Drug-Delivery Approach Data Shows a PK Profile that May [...]
Tris Pharma Announces Acceptance of New Publication Highlighting Promise of Dual NOP-MOP (dual-NMR) Agonists for the Treatment of Moderate-to-Severe Pain
08/01/2026
– Preferential MOP agonists such as oxycodone are often required for effective management of moderate to severe pain but come with significant risks of addiction and overdose – – With Dual NMR agonists, NOP and MOP [...]
PharmAla To Supply Østfold Hospital Trust with LaNeo™ MDMA for Clinical Research
08/01/2026
TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Alkeus Pharmaceuticals to Present Corporate Update at the 44th Annual J.P. Morgan Healthcare Conference
08/01/2026
CAMBRIDGE, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that Michel [...]
PCI Biotech announces discontinuation of R&D operations and continues evaluation of future options
08/01/2026
Oslo (Norway), 8 January 2026 – PCI Biotech (OSE: PCIB). Reference is made to the company’s latest announcement dated 23 rd October 2025. The external evaluation of a new bioprocessing technology has been concluded, [...]
Flare Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
08/01/2026
CAMBRIDGE, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other [...]
Illumina and PREMIA partner to expand clinical access to CGP in Asia
08/01/2026
TAIPEI, Taiwan, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Illumina Taiwan Biotechnology Co., Ltd., and Precision Medicine Asia, Limited (PREMIA), a leading Asian cancer clinical-genomic screening network, today announced the [...]

Pages